Interferon News and Research

RSS

Research findings may speed the development of vaccines for Chlamydia and other STDs

Using a novel mouse model that allows scientists to study how the immune system’s fighter cells respond to invaders in the genital tract during the initial stage of infection, researchers have found a way to track immunity against Chlamydia trachomatis.

26 Jul 2006

Nexavar approved in Europe for treatment of advanced kidney cancer

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc have announced that the European Commission has granted marketing authorization to Nexavar (sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma.

24 Jul 2006

New hope for patients with aggressive multiple sclerosis

A new combination treatment regime, for patients with aggressive forms of multiple sclerosis (MS), is offering new hope to a group of patients who would otherwise be at high risk of early disability.

18 Jul 2006

Statins stop the replication of the hepatitis C virus

A new study shows that statins, which are typically used as anti-cholesterol medications, can inhibit the replication of the hepatitis C virus (HCV).

9 Jul 2006

Nventa granted European patent covering heat shock protein fusion to treat influenza

Nventa Biopharmaceuticals Corporation announced that the European Patent Office has granted Patent Number EP 941,315 to Nventa.

8 Jun 2006

Sunitinib shows promise in treating metastatic renal cell cancer

A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options, according to an article in the June 7 issue of the Journal of the American Medical Association.

7 Jun 2006

Glivec the best news yet for cancer victims

In what is great news for those suffering from chronic myeloid leukaemia (CML), the drug Glivec looks like being one of the biggest breakthroughs in cancer therapy for a years.

7 Jun 2006

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006

New findings offer hope for vaccine against AIDS

AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought.

6 Jun 2006

MS sufferers relieved as drug Tysabri goes back on the market

The Food and Drug Administration in the U.S. has given it's approval for the multiple sclerosis drug Tysabri to be put back on the market.

6 Jun 2006

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

According to a new study, the drug sunitinib malate (Sutent.) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC).

5 Jun 2006

Study reveals how production of interferon gamma is controlled in natural killer cells

A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.

31 May 2006

Largest U.S. hepatitis C trial yields treatment insights

Community-Based WIN-R Study Shows Significantly Better Outcomes with Weight-Based Dosing

24 May 2006

Depression in multiple sclerosis patients clue to better treatment

Depression increases in some patients with multiple sclerosis over time, according to neuropsychologists, and this research finding could help reduce depression in patients and aid in better treatment strategies.

17 May 2006

Interferon-gamma plays a critical role in damaging the cells that produce myelin

A new way to preserve the cells that surround and protect nerves could lead to new treatments for demyelinating diseases such a multiple sclerosis, a research team reports in the May 10, 2006, issue of the Journal of Neuroscience.

10 May 2006

Circulating tumor cells in the bone marrow of patients with metastatic renal cell carcinoma may be prognostic of outcome

Circulating tumor cells in the blood and bone marrow have been examined in a variety of malignancies, including colorectal, breast, and head & neck cancers, to determine their prognostic significance.

8 May 2006

Epstein-Barr virus may trigger multiple sclerosis

Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus.

3 May 2006

Researchers find gene connected to Lupus

Researchers at the University of Minnesota have identified a variant of a gene that is present in most people with lupus, a complex and chronic autoimmune disease.

20 Apr 2006

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.

11 Apr 2006

Proteins could help predict whether moles will progress into melanoma

For the first time, researchers studying patients with abnormal moles have identified proteins that could help predict whether such moles will progress into melanoma, the deadliest form of skin cancer.

7 Apr 2006

Interferon News and Research

Research findings may speed the development of vaccines for Chlamydia and other STDs

Nexavar approved in Europe for treatment of advanced kidney cancer

New hope for patients with aggressive multiple sclerosis

Statins stop the replication of the hepatitis C virus

Nventa granted European patent covering heat shock protein fusion to treat influenza

Sunitinib shows promise in treating metastatic renal cell cancer

Glivec the best news yet for cancer victims

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

New findings offer hope for vaccine against AIDS

MS sufferers relieved as drug Tysabri goes back on the market

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

Study reveals how production of interferon gamma is controlled in natural killer cells

Largest U.S. hepatitis C trial yields treatment insights

Depression in multiple sclerosis patients clue to better treatment

Interferon-gamma plays a critical role in damaging the cells that produce myelin

Circulating tumor cells in the bone marrow of patients with metastatic renal cell carcinoma may be prognostic of outcome

Epstein-Barr virus may trigger multiple sclerosis

Researchers find gene connected to Lupus

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Proteins could help predict whether moles will progress into melanoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News